NFE2L2 and type 1 diabetes mellitus: In our previous study, we showed that the PPARα agonist FF prevents T1D-induced renal oxidative stress, cell apoptosis, inflammation, fibrosis, and dysfunction 19, and that this is associated with an increase in Nrf2 activation.